TY - JOUR
T1 - Chondrogenesis of human mesenchymal stem cells encapsulated in a hydrogel construct
T2 - Neocartilage formation in animal models as both mice and rabbits
AU - Park, Ji Sun
AU - Woo, Dae Gyun
AU - Yang, Han Na
AU - Lim, Hye Jin
AU - Park, Kyong Mi
AU - Na, Kun
AU - Park, Keun Hong
PY - 2010/3/1
Y1 - 2010/3/1
N2 - In this study, in vivo studies, both nude mouse and rabbit cartilage defect, were tested for chondrogenesis using stem cells (SCs) using growth factor. Specifically, human mesenchymal stem cells (hMSCs) were embedded in a hydrogel scaffold, which was coencapsulated with transforming growth factor-β3 (TGF-β3). The specific extracellular matrices (ECMs) released from hMSCs transplanted into the animal were assessed via glycosaminoglycan (GAG)/DNA content, RT-PCR, real time-QPCR, immunohistochemical (IHC), and Safranin-O staining and were observed up to 7 weeks after injection. By detection of ECMs the GAG content per cell remained constant for all formulations, indicating that the dramatic increase in cell number for samples with TGF-β3 was accompanied by the maintenance of the cell phenotypes. The histological and IHC staining of the newly repaired tissues observed after treatment with TGF-β3 mixed with hMSCs evidenced hyaline cartilage-like characteristics. Moreover, the results observed with the animal model (rabbit) treated with hMSCs embedded in the growth factor-containing hydrogel indicate that the implantation of mixed cells with TGF-β3 may constitute a clinically efficient method for the regeneration of hyaline articular cartilage.
AB - In this study, in vivo studies, both nude mouse and rabbit cartilage defect, were tested for chondrogenesis using stem cells (SCs) using growth factor. Specifically, human mesenchymal stem cells (hMSCs) were embedded in a hydrogel scaffold, which was coencapsulated with transforming growth factor-β3 (TGF-β3). The specific extracellular matrices (ECMs) released from hMSCs transplanted into the animal were assessed via glycosaminoglycan (GAG)/DNA content, RT-PCR, real time-QPCR, immunohistochemical (IHC), and Safranin-O staining and were observed up to 7 weeks after injection. By detection of ECMs the GAG content per cell remained constant for all formulations, indicating that the dramatic increase in cell number for samples with TGF-β3 was accompanied by the maintenance of the cell phenotypes. The histological and IHC staining of the newly repaired tissues observed after treatment with TGF-β3 mixed with hMSCs evidenced hyaline cartilage-like characteristics. Moreover, the results observed with the animal model (rabbit) treated with hMSCs embedded in the growth factor-containing hydrogel indicate that the implantation of mixed cells with TGF-β3 may constitute a clinically efficient method for the regeneration of hyaline articular cartilage.
KW - Cartilage tissue engineering
KW - Human mesenchymal stem cells
KW - Thermosensitive hydrogel
KW - Transforming growth factor-β3 (TGF-β3)
KW - p(NIPAAm-co-AAc)
UR - https://www.scopus.com/pages/publications/75749092630
U2 - 10.1002/jbm.a.32341
DO - 10.1002/jbm.a.32341
M3 - Article
C2 - 19296541
AN - SCOPUS:75749092630
SN - 1549-3296
VL - 92
SP - 988
EP - 996
JO - Journal of Biomedical Materials Research - Part A
JF - Journal of Biomedical Materials Research - Part A
IS - 3
ER -